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Familial Mediterranean fever (FMF) is an auto-inflammatory disease characterized by 
periodic episodes of fever and recurrent polyserositis. It is caused by a dysfunction of 
pyrin (or marenostrin) as a result of a mutation within the MEFV gene. It occurs most-
ly in individuals of Mediterranean origin; however, it has also been reported in non-
Mediterranean populations. In this report, we describe the first case of FMF in a Kore-
an child. As eight-year-old boy presented recurrent febrile attacks from an unknown 
cause, an acute scrotum and renal amyloidosis. He also showed splenomegaly, 
lymphadenopathy, pleural effusion, ascites and elevated acute phase reactants. After 
MEFV gene analysis, he was diagnosed as FMF combined with amyloidosis. 
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INTRODUCTION
Familial Mediterranean fever (FMF) is a hereditary auto-inflammatory disease, 
caused by mutation(s) in the MEFV gene.1-4 It manifests as repetitive fever epi-
sodes combined with one or more symptoms of sterile arthritis or serositis.1-4 FMF 
is endemic to those of Mediterranean descent; however, sporadic cases have been 
reported in non-Mediterranean persons beyond this region.4-6 Especially, reports of 
FMF are uncommon in the Far East although few reports and mutation studies 
have been conducted in Japanese patients.6 Accordingly, FMF is not familiar to cli-
nicians in this area and might be misdiagnosed as other auto-inflammatory diseas-
es. The Tel-Hashomer criteria can help with clinically diagnosing the disease; 
however, the same criteria are also indicative of inflammatory diseases. The 
MEFV gene for FMF has been cloned and DNA analysis can be useful in diagnos-
ing FMF when patient(s) do not wholly fulfill the diagnostic criteria. Herein, we 
describe the first case of FMF confirmed by molecular analysis of the MEFV gene 
in a Korean patient who showed recurrent clinical symptoms. 
CASE REPORT
An eight-year-old boy was referred to our hospital due to generalized edema for 
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with 24-hour collected urine. Different markers for autoim-
mune diseases such as anti-nuclear antibody, and anti-car-
diolipin antibody were negative and complement levels as 
well as immunoglobulin concentrations were all within 
normal range.
After admission, he complained of abdominal pain and 
abdominal ultrasonography revealed slightly increased re-
nal parenchymal echogenicity with splenomegaly (11 cm) 
and no hydrocele in both scrotal sacs. Abdominal computed 
tomography showed enlargement of bilateral kidneys; a 
well-enhancing mass lesion in the right common iliac chain; 
small bowel mesentery, suspected as lymphadenopathy; a 
small amount of ascites; and pleural effusion. Echocardiog-
raphy showed minimal pericardial effusion with decreased 
deceleration time of the mitral valve (80-100 ms), which 
suggested a poor prognosis.
Renal biopsy was performed for evaluation of the massive 
proteinuria, and the pathologic diagnosis was confirmed as 
amyloidosis type AA (Fig. 1). Tests for monoclonal gam-
mopathy to rule out AL amyloidosis, including serum/urine 
protein electrophoresis, immunofixation electrophoresis, 
and serum κ-, λ-free light chain assays, were all negative. 
Cochicine therapy was started with a dose of 0.025 mg/kg/
day under the impression of FMF and his clinical symp-
two weeks and sudden onset of scrotal swelling that oc-
curred two days prior to admission. Since one year before 
the admission, he had repetitive, acute, self-limited epi-
sodes of fever at varying intervals with an elevated level of 
acute phase reactants. Despite thorough evaluation, the rea-
son for the fever was unable to be determined. After an ini-
tial examination, he had been followed up under the im-
pression of juvenile rheumatoid arthritis even though he did 
not demonstrate joint symptoms. Family history revealed 
that his father died due to myocardial infarction at the age 
of 40 and there was no history of renal disease, periodic fe-
ver or auto-inflammatory disease. 
Upon physical examination, his fever was 38.4°C, blood 
pressure was 108/75 mm Hg, and body weight increased 
from 23 kg to 26 kg in last two weeks prior to admission. 
Pretibial pitting edema and swollen abdomen were also ob-
served without rash. Laboratory findings on admission 
showed inflammatory conditions of very high C-reactive 
protein (140 mg/L) and high erythrocyte sedimentation rate 
(120 mm/hr). Anemia (8.4 g/dL), hypoalbuminemia (1.0 g/
dL), and markedly elevated fibrinogen (1029 mg/dL) were 
observed as well. Massive nephrotic-range proteinuria 
(urine protein/creatinine ratio was 14.49, total microprotein 
12297 mg/day, microalbumin 10249 mg/day) was observed 
Fig. 1. The mesangium is expanded by pinkish amorphous material (PAS, ×400) (A). This material shows apple green birefringence under 
the polarized microscopy after Congo red staining (×200) (B) and immunoreactivity to the amyloid A antibody (×200) (C). An electron mi-
croscopy reveals haphazardly arranged non-branching fibrils measuring 8-10 nm in diameter. (×50000) (D). 
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ferential diagnosis, other genes, including MVK for HIDS, 
NLRP3 for MWS and TNFRSF1A for FPF, that cause simi-
lar phenotypes were also analysed. Only several SNPs were 
identified in the analysis of MVK, NLRP3 and TNFRSF1A 
genes (Table 1).  
DISCUSSION
FMF is a hereditary auto-inflammatory disease character-
ized by periodic episodes of fever and polyserositis at irreg-
ular intervals.1-4 In 1960, Fox and Morrelli described the 
first case of FMF in a patient of non-Mediterranean ethnic 
origin.7 Thereafter, sporadic cases among Ashkenazi Jews, 
Germans and Anglo-Saxons have been continuously report-
toms gradually improved. 
In order to make the clinical diagnosis, the clinical enti-
ties of periodic fever and systemic inflammatory reactions 
combined with amyloidosis were considered, which were 
indicative of FMF (OMIM no. 249100), familial periodic 
fever (FPF, TRAPS; OMIM no. 142680), hyperimmuno-
globulinemia D with periodic fever syndrome (HIDS; 
OMIM no. 260920), and Muckle-Wells syndrome (MWS; 
OMIM no. 191900). The patient was able to be diagnosed 
as FMF since he showed typical attacks fulfilling three ma-
jor criteria (pleuritis, fever and incomplete abdominal at-
tack) of the Tel-Hashomer criteria. To verify the underlying 
cause of AA amyloidosis, DNA analysis of the MEFV gene 
was initially performed and two point mutations (p.
Pro369Ser, p.Arg408Gln) were identified (Fig. 2). For dif-
Fig. 2. Results of the DNA analysis of the MEFV gene.
Table 1. SNPs Identified in the Patient after Analysis of the MVK, NLRP3, TNFRSF1A and MEFV Genes
Gene Site Polymorphisms SNP-db no.  Patient’s genotype 
MVK       Intron 6 c632-18A>G rs2270375   A/G
       Exon 9 c831C>T rs104895353   C/T
NLRP3 Exon 3 c732G>A rs3806268   G/A
Exon 3 c1308C>T rs34298354   C/T
Intron 5 c2499-40G>A rs10754557   G/A
TNFRSF1A Exon 1 c36A>G rs767455   A/G
Intron 6 c625+10A>G rs1800693   A/G
Intron 8     c769-23T>C rs10849443   C/C
MEFV Exon 3 c942C>T rs224213   T/T
Intron 4 c1356+44A>G rs224212          A/G
Exon 5 c1428A>G rs224207    A/G
Exon 5 c1422G>A rs224208   G/A
Exon 5 c1503C>T rs76464258   C/T
　 Exon 5 c1530T>C rs224206   T/C
　 Intron 5   c1588-69G>A rs224205   G/A
　 Intron 6 c1610+96C>T rs224204   C/T
　 Intron 6  c1611-90C>T rs1231124   C/T
　 Intron 8 c1759+8C>T rs77380520   C/T
　          Exon 9 c1764A>G rs1231122    A/G
p.Pro369Ser (c.1150C>T)
A A G C C T A A G C C C C C A G C C C C T G G C C A C C G G G T G C G C C C C A T
p.Arg408Gln (c.1223G>A)
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icantly affect interaction between pyrin and PSTPIP1. How-
ever, 5 of 22 patients carrying these mutations fulfilled Tel-
Hashomer criteria for clinical diagnosis of FMF. Therefore, 
other genes causing periodic fever syndrome were analysed 
with negative results.
In addition to pathologic mutations in MEFV gene, envi-
ronmental factors and interactions of other genes are em-
phasized in the expression of the clinical phenotype.13 It 
may be important factors in FMF patients with autosomal 
dominant inheritance carrying heterozygote mutation in 
MEFV gene. The case in this report fulfilled the Tel-Hashom-
er criteria for clinical diagnosis of FMF and carried two 
mutations in the MEFV gene without any pathologic muta-
tions in the MVK, NLRP3 and TNFRSF1A genes. Even 
though the functional significance of P369S/R408Q has not 
been clearly elucidated, we assume that interactions with 
other genes may play some role in the phenotypic expres-
sion of these mutations. In a study on Turkish patients, the 
frequency of P369S was 7.6% and the genotype of P369S/
E148Q was present in 15%.14
Clinical diagnosis of FMF is not easy, especially, in pa-
tients of non-Mediterranean ethnic origin. Our case showed 
severe symptoms including renal amyloidosis at an early 
age. The most common reason for renal amyloidosis in chil-
dren in the Mediterranean area15 is FMF. There is also a pos-
sibility of another gene(s) responsible for the disease. About 
40% of the patients with clinical symptoms of FMF show 
negative results upon DNA analysis. More data on the muta-
tion spectrum of the MEFV gene and phenotypic character-
istics will increase the further understanding of the function 
of the gene and the molecular pathogenesis of the disease.
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